Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification

Diagnostics - Switzerland
doi 10.3390/diagnostics8040080
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Optimising Preoperative Risk Stratification Tools for Prostate Cancer Using mpMRI

European Radiology
MedicineNuclear MedicineRadiologyImaging
2017English

On Risk Estimation Versus Risk Stratification in Early Prostate Cancer

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2016English

Carbonic Anhydrase I as a New Plasma Biomarker for Prostate Cancer

ISRN Oncology
2012English

Pre-Treatment Risk Stratification of Prostate Cancer Patients: A Critical Review

Journal of the Canadian Urological Association
OncologyUrology
2012English

AKR1C3 Overexpression May Serve as a Promising Biomarker for Prostate Cancer Progression

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2014English

Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer

Anticancer Research
MedicineCancer ResearchOncology
2020English

Pre-Treatment Risk Stratification of Prostate Cancer Patients:A Critical Review

Canadian Urological Association Journal
Urology
2012English

Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Risk Stratification for Intermediate- And High-Risk Patients

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Risk Stratification: A Tool to Predict the Course of Active Surveillance for Localized Prostate Cancer?

BJU International
Urology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy